Scientific Sessions 2025  /  Updates in Diabetes Cardiovascular Outcome Trials  /  Once a PIONEER and now at the SOUL of the matter: cardiovascular outcomes with oral semaglutide
Logo

American Heart Association

  30
  0

Final ID:

Once a PIONEER and now at the SOUL of the matter: cardiovascular outcomes with oral semaglutide

  • Mcguire, Darren  ( UT Southwestern , Dallas , Texas , United States )
  • Busui, Rodica  ( UNIVERSITY MICHIGAN , Ann Arbor , Michigan , United States )
  • Mulvagh, Sharon  ( MAYO FOUNDATION , Rochester , Minnesota , United States )
  • Inzucchi, Silvio  ( YALE UNIVERSITY SCHOOL OF MED , Stratford , Connecticut , United States )
    • Author Disclosures:
    Darren McGuire: DO have relevant financial relationships ; Consultant:Lilly USA:Active (exists now) ; Consultant:Novartis:Active (exists now) ; Consultant:New Amsterdam:Active (exists now) ; Consultant:F. Hoffman La Roche:Active (exists now) ; Consultant:Regor:Active (exists now) ; Consultant:Metsera:Active (exists now) ; Consultant:Zealand:Active (exists now) ; Consultant:Alveus:Active (exists now) ; Consultant:Kalera:Active (exists now) ; Consultant:Neurotronic:Active (exists now) ; Consultant:Amgen:Active (exists now) ; Consultant:Lexicon:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) ; Consultant:Boehringer Ingelheim:Active (exists now) | Rodica Busui: DO have relevant financial relationships ; Consultant:Roche Diagnostic:Active (exists now) ; Consultant:Merck:Past (completed) ; Consultant:Viatris:Past (completed) ; Research Funding (PI or named investigator):Lexicon:Active (exists now) ; Research Funding (PI or named investigator):Novo Nordisk:Active (exists now) ; Consultant:Vertex:Active (exists now) ; Consultant:Averitas Pharma:Active (exists now) ; Consultant:Lexicon Pharma:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) | Sharon Mulvagh: No Answer | Silvio Inzucchi: DO have relevant financial relationships ; Advisor:Novo Nordisk:Active (exists now) ; Consultant:Bayer:Active (exists now) ; Advisor:Boehringer Ingelheim:Active (exists now) ; Advisor:AstraZeneca:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Updates in Diabetes Cardiovascular Outcome Trials

Monday, 11/10/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Making STRIDEs in diabetes: the role of incretin-based therapy in peripheral artery disease

Bonaca Marc, Verma Subodh

Integrating lessons learned from diabetes CVOTs (old and new) into clinical care

Taub Pam, Gianos Eugenia

More abstracts from these authors:
Discussant: SELECT

Mcguire Darren, Neeland Ian

Lessons to be learned from adult cardiovascular trialists

Packer Milton, Mcguire Darren

You have to be authorized to contact abstract author. Please, Login
Not Available